Tag Archives: AMGN

J.P. Morgan Maintains a Hold Rating on Amgen Inc (AMGN)

J.P. Morgan analyst Cory Kasimov maintained a Hold rating on Amgen Inc (AMGN – Research Report) yesterday and set a price target of $190. The company’s shares closed yesterday at $167.81, close to its 52-week low of $167.17. According to

Amgen Inc (AMGN) Receives a Buy from Oppenheimer

Oppenheimer analyst Jay Olson maintained a Buy rating on Amgen Inc (AMGN – Research Report) yesterday and set a price target of $220. The company’s shares closed yesterday at $179.32. Olson observed: “1Q results included non-GAAP EPS of $3.56, ahead

Amgen Inc (AMGN) Gets a Buy Rating from Cowen & Co.

In a report released yesterday, Yaron Werber from Cowen & Co. maintained a Buy rating on Amgen Inc (AMGN – Research Report), with a price target of $229. The company’s shares closed yesterday at $179.32. According to TipRanks.com, Werber is

Analysts Offer Insights on Healthcare Companies: Amgen Inc (NASDAQ: AMGN) and Amarin (NASDAQ: AMRN)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Amgen Inc (AMGN – Research Report) and Amarin (AMRN – Research Report) with bullish sentiments. Amgen Inc (AMGN) In a report released

Amgen Inc (AMGN): New Buy Recommendation for This Healthcare Giant

In a report released today, Jay Olson from Oppenheimer maintained a Buy rating on Amgen Inc (AMGN – Research Report), with a price target of $224. The company’s shares closed yesterday at $192.43. Olson said: “Preclinical data on AMGN’s small

Cantor Fitzgerald Sticks to Its Hold Rating for Amgen Inc (AMGN)

Cantor Fitzgerald analyst Alethia Young reiterated a Hold rating on Amgen Inc (AMGN – Research Report) today and set a price target of $221. The company’s shares closed on Friday at $189.98. Young wrote: “. We Reiterate our Neutral rating